Tapewire

NYSE · USD

WD

Walker & Dunlop, Inc.

Export transactions ↓
Tapewire entity
4737
SEC CIK
0001497770
Parsed reports
515

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202640
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2019 Filed Feb 20, 2019 22:01 UTC Tax withholdingCommon Stock 23,987 $54.49 $1,307,051.63
Disclosure

SEC source: 0001104659-19-009585 · a4.xml · nonDerivative · entry 3

THEOBALD STEPHEN P · CIK 0001507723 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,976

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:01 UTC GrantCommon Stock 9,175 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009585 · a4.xml · nonDerivative · entry 2

THEOBALD STEPHEN P · CIK 0001507723 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,963

F2 · shares: The restricted stock vests in three equal annual installments beginning on February 15, 2020.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:01 UTC GrantCommon Stock 36,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009585 · a4.xml · nonDerivative · entry 1

THEOBALD STEPHEN P · CIK 0001507723 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,788

F1 · shares: On March 21, 2016, the reporting person was granted an award of performance share units, which vest in the form of common stock if certain pre-established performance goals underlying the award are met over the course of a three-year period. On February 15, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the performance goals had been met, resulting in the vesting of these shares.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:02 UTC
Warner Richard CEVP & Chief Credit Officer
Tax withholdingCommon Stock 23,020 $54.49 $1,254,359.80
Disclosure

SEC source: 0001104659-19-009586 · a4.xml · nonDerivative · entry 3

Warner Richard C · CIK 0001503839 · EVP & Chief Credit Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,200

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:02 UTC
Warner Richard CEVP & Chief Credit Officer
GrantCommon Stock 9,175 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009586 · a4.xml · nonDerivative · entry 2

Warner Richard C · CIK 0001503839 · EVP & Chief Credit Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,220

F2 · shares: The restricted stock vests in three equal annual installments beginning on February 15, 2020.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:02 UTC
Warner Richard CEVP & Chief Credit Officer
GrantCommon Stock 36,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009586 · a4.xml · nonDerivative · entry 1

Warner Richard C · CIK 0001503839 · EVP & Chief Credit Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,045

F1 · shares: On March 21, 2016, the reporting person was granted an award of performance share units, which vest in the form of common stock if certain pre-established performance goals underlying the award are met over the course of a three-year period. On February 15, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the performance goals had been met, resulting in the vesting of these shares.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:01 UTC
Walker William MDirector · Chairman & CEO
GrantRestricted Stock Units · Derivative 3,211 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009584 · a4.xml · derivative · entry 8

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,211

Underlying: Common Stock · 3,211 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of the Issuer.

F6 · derivative.exercise_date: The restricted stock units will be settled in shares of the Issuer's common stock on January 31, 2024, subject to vesting acceleration pursuant to the Plan.

F6 · derivative.expiration_date: The restricted stock units will be settled in shares of the Issuer's common stock on January 31, 2024, subject to vesting acceleration pursuant to the Plan.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:01 UTC
Walker William MDirector · Chairman & CEO
GrantDeferred Stock Units · Derivative 6,423 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009584 · a4.xml · derivative · entry 7

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,423

Underlying: Common Stock · 6,423 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:01 UTC
Walker William MDirector · Chairman & CEO
Tax withholdingCommon Stock 72,679 $54.49 $3,960,278.71
Disclosure

SEC source: 0001104659-19-009584 · a4.xml · nonDerivative · entry 3

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,363,632

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:01 UTC
Walker William MDirector · Chairman & CEO
GrantCommon Stock 16,516 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009584 · a4.xml · nonDerivative · entry 2

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,436,311

F2 · shares: The restricted stock vests in three equal annual installments beginning on February 15, 2020.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:01 UTC
Walker William MDirector · Chairman & CEO
GrantCommon Stock 137,442 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009584 · a4.xml · nonDerivative · entry 1

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419,795

F1 · shares: On March 21, 2016, the reporting person was granted an award of performance share units, which vest in the form of common stock if certain pre-established performance goals underlying the award are met over the course of a three-year period. On February 15, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the performance goals had been met, resulting in the vesting of these shares.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
GrantRestricted Stock Units · Derivative 1,835 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009582 · a4.xml · derivative · entry 5

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,835

Underlying: Common Stock · 1,835 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of the Issuer.

F6 · derivative.exercise_date: The restricted stock units will be settled in shares of the Issuer's common stock on March 15 in the third calendar year following the grant date, subject to vesting acceleration pursuant to the Plan.

F6 · derivative.expiration_date: The restricted stock units will be settled in shares of the Issuer's common stock on March 15 in the third calendar year following the grant date, subject to vesting acceleration pursuant to the Plan.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
GrantDeferred Stock Units · Derivative 3,670 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009582 · a4.xml · derivative · entry 4

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,670

Underlying: Common Stock · 3,670 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
Tax withholdingCommon Stock 22,399 $54.49 $1,220,521.51
Disclosure

SEC source: 0001104659-19-009582 · a4.xml · nonDerivative · entry 3

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,602

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
GrantCommon Stock 9,175 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009582 · a4.xml · nonDerivative · entry 2

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,001

F2 · shares: The restricted stock vests in three equal annual installments beginning on February 15, 2020.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
GrantCommon Stock 36,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009582 · a4.xml · nonDerivative · entry 1

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,826

F1 · shares: On March 21, 2016, the reporting person was granted an award of performance share units, which vest in the form of common stock if certain pre-established performance goals underlying the award are met over the course of a three-year period. On February 15, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the performance goals had been met, resulting in the vesting of these shares.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Smith Howard W IIIDirector · President
GrantRestricted Stock Units · Derivative 2,150 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009581 · a4.xml · derivative · entry 11

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,150

Underlying: Common Stock · 2,150 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of the Issuer.

F6 · derivative.exercise_date: The restricted stock units will be settled in shares of the Issuer's common stock on March 15 in the third calendar year following the grant date, subject to vesting acceleration pursuant to the Plan.

F6 · derivative.expiration_date: The restricted stock units will be settled in shares of the Issuer's common stock on March 15 in the third calendar year following the grant date, subject to vesting acceleration pursuant to the Plan.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Smith Howard W IIIDirector · President
GrantDeferred Stock Units · Derivative 4,301 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009581 · a4.xml · derivative · entry 10

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,301

Underlying: Common Stock · 4,301 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Smith Howard W IIIDirector · President
Tax withholdingCommon Stock 35,004 $54.49 $1,907,367.96
Disclosure

SEC source: 0001104659-19-009581 · a4.xml · nonDerivative · entry 3

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,094

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Smith Howard W IIIDirector · President
GrantCommon Stock 11,469 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009581 · a4.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,098

F2 · shares: The restricted stock vests in three equal annual installments beginning on February 15, 2020.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 22:00 UTC
Smith Howard W IIIDirector · President
GrantCommon Stock 68,720 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-009581 · a4.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,629

F1 · shares: On March 21, 2016, the reporting person was granted an award of performance share units, which vest in the form of common stock if certain pre-established performance goals underlying the award are met over the course of a three-year period. On February 15, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the performance goals had been met, resulting in the vesting of these shares.

Read SEC document
February 06, 2019 Filed Feb 8, 2019 22:01 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 10,897 $51.32 $559,227.50
Disclosure

SEC source: 0001104659-19-006846 · a4.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,909

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.005 to $51.79. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 06, 2019 Filed Feb 8, 2019 22:01 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 51,107 $50.43 $2,577,116.47
Disclosure

SEC source: 0001104659-19-006846 · a4.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,806

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.00. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 31, 2019 Filed Feb 4, 2019 22:42 UTC Exercise / conversionDeferred Stock Units · Derivative 9,708 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-005590 · a4.xml · derivative · entry 3

THEOBALD STEPHEN P · CIK 0001507723 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,708 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on January 31, 2019 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

F2 · derivative.expiration_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on January 31, 2019 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

Read SEC document
January 31, 2019 Filed Feb 4, 2019 22:42 UTC Tax withholdingCommon Stock 4,461 $48.07 $214,440.27
Disclosure

SEC source: 0001104659-19-005590 · a4.xml · nonDerivative · entry 2

THEOBALD STEPHEN P · CIK 0001507723 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,138

Read SEC document
January 31, 2019 Filed Feb 4, 2019 22:42 UTC Exercise / conversionCommon Stock 9,708 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-005590 · a4.xml · nonDerivative · entry 1

THEOBALD STEPHEN P · CIK 0001507723 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 31, 2019 Filed Feb 4, 2019 22:43 UTC
Walker William MDirector · Chairman & CEO
Exercise / conversionDeferred Stock Units · Derivative 24,271 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-005591 · a4.xml · derivative · entry 6

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,271 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on January 31, 2019 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

F2 · derivative.expiration_date: The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on January 31, 2019 pursuant to the Walker & Dunlop, Inc. Management Deferred Stock Unit Purchase Plan.

Read SEC document
January 31, 2019 Filed Feb 4, 2019 22:43 UTC
Walker William MDirector · Chairman & CEO
Tax withholdingCommon Stock 8,033 $48.07 $386,146.31
Disclosure

SEC source: 0001104659-19-005591 · a4.xml · nonDerivative · entry 2

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,282,353

Read SEC document
January 31, 2019 Filed Feb 4, 2019 22:43 UTC
Walker William MDirector · Chairman & CEO
Exercise / conversionCommon Stock 24,271 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-005591 · a4.xml · nonDerivative · entry 1

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,290,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 18, 2019 Filed Jan 23, 2019 21:31 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 37,996 $50.06 $1,902,159.55
Disclosure

SEC source: 0001104659-19-002967 · a4.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,913

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.25. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 17, 2019 Filed Jan 18, 2019 21:30 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
SaleCommon Stock 18,815 $48.01 $903,372.12
Disclosure

SEC source: 0001104659-19-002506 · a4.xml · nonDerivative · entry 2

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,176

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.08. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 16, 2019 Filed Jan 18, 2019 21:30 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
SaleCommon Stock 3,879 $48.02 $186,250.19
Disclosure

SEC source: 0001104659-19-002506 · a4.xml · nonDerivative · entry 1

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,991

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.13. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 14, 2018 Filed Dec 17, 2018 21:31 UTC PurchaseCommon Stock 1,000 $42.20 $42,201.90
Disclosure

SEC source: 0001104659-18-073340 · a4.xml · nonDerivative · entry 1

SCHMALTZ DANA L · CIK 0001104397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,773

Read SEC document
December 07, 2018 Filed Dec 17, 2018 21:31 UTC
Walker William MDirector · Chairman & CEO
GiftCommon Stock 590 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-073339 · a4.xml · nonDerivative · entry 4

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · As Custodian for Son 3

Disclosed balance after: 3,955

Read SEC document
December 07, 2018 Filed Dec 17, 2018 21:31 UTC
Walker William MDirector · Chairman & CEO
GiftCommon Stock 590 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-073339 · a4.xml · nonDerivative · entry 3

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · As Custodian for Son 2

Disclosed balance after: 3,955

Read SEC document
December 07, 2018 Filed Dec 17, 2018 21:31 UTC
Walker William MDirector · Chairman & CEO
GiftCommon Stock 590 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-073339 · a4.xml · nonDerivative · entry 2

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · As Custodian for Son 1

Disclosed balance after: 3,955

Read SEC document
December 07, 2018 Filed Dec 17, 2018 21:31 UTC
Walker William MDirector · Chairman & CEO
GiftCommon Stock 7,070 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-073339 · a4.xml · nonDerivative · entry 1

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,266,115

Read SEC document
December 06, 2018 Filed Dec 12, 2018 21:30 UTC OtherCommon Stock 46.0017 $44.04 $2,025.73
Disclosure

SEC source: 0001104659-18-072557 · a4.xml · nonDerivative · entry 2

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,057.27

Read SEC document
December 06, 2018 Filed Dec 12, 2018 21:30 UTC OtherCommon Stock 134.6248 $43.87 $5,905.99
Disclosure

SEC source: 0001104659-18-072557 · a4.xml · nonDerivative · entry 1

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,011.2683

Read SEC document
December 04, 2018 Filed Dec 6, 2018 21:32 UTC
Smith Howard W IIIDirector · President
GrantDividend Equivalent Rights · Derivative 120.1795 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-071700 · a4.xml · derivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 411.1463

Underlying: Common Stock · 120.1795 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 21:31 UTC
Lucas Richard MEVP & Gen Counsel & Secretary
GrantDividend Equivalent Rights · Derivative 54.8417 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-071699 · a4.xml · derivative · entry 1

Lucas Richard M · CIK 0001503845 · EVP & Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187.6189

Underlying: Common Stock · 54.8417 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 21:31 UTC
THEOBALD STEPHEN PEVP & Chief Financial Officer
GrantDividend Equivalent Rights · Derivative 40.6844 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-071698 · a4.xml · derivative · entry 1

THEOBALD STEPHEN P · CIK 0001507723 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153.7111

Underlying: Common Stock · 40.6844 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 21:30 UTC
Walker William MDirector · Chairman & CEO
GrantDividend Equivalent Rights · Derivative 55.7182 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-071697 · a4.xml · derivative · entry 1

Walker William M · CIK 0001503841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190.6177

Underlying: Common Stock · 55.7182 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:00 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 400 $53.20 $21,279.00
Disclosure

SEC source: 0001104659-18-060360 · a4.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,909

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.18 to $53.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:00 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 24,600 $52.87 $1,300,589.70
Disclosure

SEC source: 0001104659-18-060360 · a4.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,309

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.17 to $53.17. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Excludes 388,497 shares previously reported as owned directly, which were contributed to The HIII 2011 Trust for no consideration since the date of the reporting person's last Form 4.

Read SEC document
September 05, 2018 Filed Sep 7, 2018 21:00 UTC PurchaseCommon Stock 107.6434 $54.62 $5,879.48
Disclosure

SEC source: 0001104659-18-055821 · a4.xml · nonDerivative · entry 2

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,876.6435

Read SEC document
September 05, 2018 Filed Sep 7, 2018 21:00 UTC PurchaseCommon Stock 36.7134 $54.93 $2,016.67
Disclosure

SEC source: 0001104659-18-055821 · a4.xml · nonDerivative · entry 1

Bowers Alan J · CIK 0001503849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,769.0001

F1 · balance_after: The reporting persons's prior Form 4, filed on June 8, 2018, omitted 0.0766 shares from the amount of securities acquired in the reported transaction and, as a result, incorrectly stated the number of securities beneficially owned following the reported transaction.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 21:04 UTC
Smith Howard W IIIDirector · President
GrantDividend Equivalent Rights · Derivative 97.0031 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-055615 · a4.xml · derivative · entry 8

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290.9668

Underlying: Common Stock · 97.0031 shares

Expires not disclosed

F3 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 21:04 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 2 $54.93 $109.86
Disclosure

SEC source: 0001104659-18-055615 · a4.xml · nonDerivative · entry 2

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 606,406

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 21:04 UTC
Smith Howard W IIIDirector · President
SaleCommon Stock 24,998 $54.28 $1,356,778.95
Disclosure

SEC source: 0001104659-18-055615 · a4.xml · nonDerivative · entry 1

Smith Howard W III · CIK 0001503844 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 606,408

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.84 to $54.82. The reporting person undertakes to provide Walker & Dunlop, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.